SEC Form 4 · accession 0001209191-17-033634
TANDEM DIABETES CARE INC · TNDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian B Hansen
Officer — EVP & CHIEF COMMERCIAL OFFICER
Period of report
May 15, 2017
Accepted (ET)
May 18, 2017 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 15, 2017 | A | 5,303 | $0.77 | A | 8,974 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF3,F4,F5 | $0.90 | May 17, 2017 | A | 105,000 | A | — | — | Common Stock | 105,000 | 105,000 | D |
Explanation of responses
- F1The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 16, 2016 through May 15, 2017. This transaction is also exempt under Rule 16b-3(c).
- F2In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on May 15, 2017.
- F3Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan.
- F4All shares subject to the option will vest as to 25% on 5/17/2018 and the remainder in 36 equal monthly installments thereafter.
- F5The expiration date for these options is 10 years from the date of grant.